← Back to Clinical Trials
Recruiting NCT03848052

Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Lung Cancer
Sponsor UNICANCER
Study Type OBSERVATIONAL
Phase N/A
Enrollment 70,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2017-10-02
Completion 2024-09-20

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This database compiles data from existing data available from patient's electronic medical records (EMR) at the 38 participating hospitals (20 French comprehensive cancer centers and 18 public hospitals).

Eligibility Criteria

Inclusion criteria : * Adult (over 18) * Treated (with radiotherapy or systemic anti-cancer treatment) for a lung cancer or diagnosed with metastatic lung cancer over the selection period at one of the participating site Exclusion criteria \- None

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE LUNG CANCER TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}